BlockTrack  -- [Image ~ www.biospectrumindia.com]


Researchers at the Indian Institute of Technology, Madras (IIT Madras) have developed 'BlockTrack', a first-of-its-kind blockchain-based secure medical data and information exchange system for a mobile phone-based application. This system is currently being field-tested at IIT Madras Institute Hospital.

BlockTrack project, which has got CSR support from IT giant Infosys during the height of the COVID-19 pandemic last year, is developed to integrate primary healthcare; prescription; pharmacy; distribution and insurance network.

BlockTrack aims to securely digitize healthcare information systems while ensuring the protection of sensitive personal information and medical records by decentralizing the control and ownership of patient data, through a blockchain-based innovation. The BlockTrack innovation is now protected through a provisional IP filed with the Indian Patent Office.

The Android version of the application has been developed separately for both patients as well as doctors. BlockTrack’s algorithm generates identification codes for users and ensures uniqueness across boundaries with very little chance for duplication. It opens up the promise of universal and transferable healthcare information management with a strong emphasis on data privacy and tracking the spread of infectious diseases across geographies.

BlockTrack allows the interoperability of systems from multiple hospitals, institutes, and healthcare organizations. It integrates medical supply chain management and proactive tracking of the spread of contagious infections. The patient can choose to visit any healthcare facility which is on BlockTrack’s blockchain network without having any concerns about duplication of records or re-registrations.

BlockTrack is developed by a team led by Prof. Prabhu Rajagopal, Lead Faculty for Remote Diagnostics, Center for Nondestructive Evaluation (CNDE), Department of Mechanical Engineering, IIT Madras.

Post a Comment

Previous Post Next Post
Like this content? Sign up for our daily newsletter to get latest updates.